Stay updated with breaking news from Moderna miller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Second COVID-19 vaccine set for OK in U.S. with panel endorsement FILE - In this Monday, July 27, 2020 file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. On Thursday, Dec. 17, 2020, a panel of independent experts is meeting to discuss a vaccine made by Moderna. The panel s review for the Food and Drug Administration is the next-to-last step before the agency decides whether the shots can be used on an emergency basis. (AP Photo/Hans Pennink) FILE - A man stands outside an entrance to a Moderna, Inc., building, Monday, May 18, 2020, in Cambridge, Mass. A second COVID-19 vaccine moved closer to joining the U.S. fight against the pandemic Thursday, Dec. 17, 2020 as government experts convened for a final public review of its safety and effectiveness. The shot from Moderna and the National Institutes of Health is urgently needed as the country continue ....
by: MATTHEW PERRONE and LAURAN NEERGAARD, Associated Press Posted: Dec 17, 2020 / 09:57 PM EST WASHINGTON (AP) The head of the Food and Drug Administration said late Thursday that his agency will move to quickly authorize the second COVID-19 vaccine to fight the pandemic, hours after the shot won the key endorsement of a government advisory panel. FDA Commissioner Stephen Hahn said in a statement that regulators have communicated their plans to drugmaker Moderna, which co-developed the vaccine with the National Institutes of Health. The announcement came after a panel of FDA advisers, in a 20-0 vote, ruled that the benefits of the vaccine outweighed the risks for those 18 years old and up. ....
FDA advisory panel endorses Moderna's coronavirus vaccine themonitor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themonitor.com Daily Mail and Mail on Sunday newspapers.